Log in to save to my catalogue

Sonodynamical reversion of immunosuppressive microenvironment in prostate cancer via engineered exos...

Sonodynamical reversion of immunosuppressive microenvironment in prostate cancer via engineered exos...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6dec4a87338848139d86c7f247a28e24

Sonodynamical reversion of immunosuppressive microenvironment in prostate cancer via engineered exosomes

About this item

Full title

Sonodynamical reversion of immunosuppressive microenvironment in prostate cancer via engineered exosomes

Publisher

England: Taylor & Francis

Journal title

Drug delivery, 2022-12, Vol.29 (1), p.702-713

Language

English

Formats

Publication information

Publisher

England: Taylor & Francis

More information

Scope and Contents

Contents

Prostate cancer (PCa) responds poorly to routine immunotherapy due to the tumor immunosuppressive microenvironment. Here, we describe an ultrasound-based drug delivery strategy to stimulate potent anti-tumor immunity via exosomes encapsulated with sonosensitizers Chlorin e6 (Ce6) and immune adjuvant R848, namely Exo
Ce6+R848
. Exo
Ce6+R848...

Alternative Titles

Full title

Sonodynamical reversion of immunosuppressive microenvironment in prostate cancer via engineered exosomes

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_6dec4a87338848139d86c7f247a28e24

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6dec4a87338848139d86c7f247a28e24

Other Identifiers

ISSN

1071-7544

E-ISSN

1521-0464

DOI

10.1080/10717544.2022.2044937

How to access this item